Figure 5. Up-regulated miRs mediating efficacy in gastric cancer-related in vivo models. (A): miRs targeting cell-cycle-related proteins. BTG2: BTG family member 2; CCNG2: cyclin-G2. (B): miRs interfering with other targets. CMTM3: CKLF like MARVEL transmembrane domain containing 3; CRMP1: collapsin response mediator protein 1, CSMD1: CUB and sushi multiple domains 1; KDM2B: Lysine (K)-specific demethylase 2B; TIA-1: T cell intracellular antigen-1.
